Literature DB >> 24913158

His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.

Hanna-Kirsti S Leiros1, Susann Skagseth2, Kine Susann Waade Edvardsen2, Marit Sjo Lorentzen2, Gro Elin Kjæreng Bjerga2, Ingar Leiros2, Ørjan Samuelsen3.   

Abstract

Metallo-β-lactamases (MBLs) are the causative mechanism for resistance to β-lactams, including carbapenems, in many Gram-negative pathogenic bacteria. One important family of MBLs is the Verona integron-encoded MBLs (VIM). In this study, the importance of residues Asp120, Phe218, and His224 in the most divergent VIM variant, VIM-7, was investigated to better understand the roles of these residues in VIM enzymes through mutations, enzyme kinetics, crystal structures, thermostability, and docking experiments. The tVIM-7-D120A mutant with a tobacco etch virus (TEV) cleavage site was enzymatically inactive, and its structure showed the presence of only the Zn1 ion. The mutant was less thermostable, with a melting temperature (T(m)) of 48.5°C, compared to 55.3 °C for the wild-type tVIM-7. In the F218Y mutant, a hydrogen bonding cluster was established involving residues Asn70, Asp84, and Arg121. The tVIM-7-F218Y mutant had enhanced activity compared to wild-type tVIM-7, and a slightly higher Tm (57.1 °C) was observed, most likely due to the hydrogen bonding cluster. Furthermore, the introduction of two additional hydrogen bonds adjacent to the active site in the tVIM-7-H224Y mutant gave a higher thermostability (T(m), 62.9 °C) and increased enzymatic activity compared to those of the wild-type tVIM-7. Docking of ceftazidime in to the active site of tVIM-7, tVIM-7-H224Y, and VIM-7-F218Y revealed that the side-chain conformations of residue 224 and Arg228 in the L3 loop and Tyr67 in the L1 loop all influence possible substrate binding conformations. In conclusion, the residue composition of the L3 loop, as shown with the single H224Y mutation, is important for activity particularly toward the positively charged cephalosporins like cefepime and ceftazidime.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913158      PMCID: PMC4136046          DOI: 10.1128/AAC.02735-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.

Authors:  Mariana Castanheira; Lalitagauri M Deshpande; Rodrigo E Mendes; Eduardo Rodriguez-Noriega; Ronald N Jones; Rayo Morfin-Otero
Journal:  J Antimicrob Chemother       Date:  2010-10-20       Impact factor: 5.790

2.  Hydroxyl groups in the (beta)beta sandwich of metallo-beta-lactamases favor enzyme activity: a computational protein design study.

Authors:  Peter Oelschlaeger; Stephen L Mayo
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

3.  Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.

Authors:  Ørjan Samuelsen; Mariana Castanheira; Timothy R Walsh; James Spencer
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

4.  Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.

Authors:  Patricia Lassaux; Daouda A K Traoré; Elodie Loisel; Adrien Favier; Jean-Denis Docquier; Jean Sébastien Sohier; Clémentine Laurent; Carine Bebrone; Jean-Marie Frère; Jean-Luc Ferrer; Moreno Galleni
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

5.  Hydroxyl groups in the betabeta sandwich of metallo-beta-lactamases favor enzyme activity: Tyr218 and Ser262 pull down the lid.

Authors:  Peter Oelschlaeger; Juergen Pleiss
Journal:  J Mol Biol       Date:  2006-11-11       Impact factor: 5.469

6.  Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.

Authors:  Renata C Picão; Laurent Poirel; Ana C Gales; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

7.  Metal binding Asp-120 in metallo-beta-lactamase L1 from Stenotrophomonas maltophilia plays a crucial role in catalysis.

Authors:  James D Garrity; Anne L Carenbauer; Lissa R Herron; Michael W Crowder
Journal:  J Biol Chem       Date:  2003-10-22       Impact factor: 5.157

8.  The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.

Authors:  I Garcia-Saez; J-D Docquier; G M Rossolini; O Dideberg
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

9.  Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.

Authors:  James Spencer; Jonathan Read; Richard B Sessions; Steven Howell; G Michael Blackburn; Steven J Gamblin
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

10.  Metallo-β-lactamases withstand low Zn(II) conditions by tuning metal-ligand interactions.

Authors:  Javier M González; María-Rocío Meini; Pablo E Tomatis; Francisco J Medrano Martín; Julia A Cricco; Alejandro J Vila
Journal:  Nat Chem Biol       Date:  2012-06-24       Impact factor: 15.040

View more
  9 in total

1.  Structure, activity and thermostability investigations of OXA-163, OXA-181 and OXA-245 using biochemical analysis, crystal structures and differential scanning calorimetry analysis.

Authors:  Bjarte Aarmo Lund; Ane Molden Thomassen; Trine Josefine Olsen Carlsen; Hanna Kirsti S Leiros
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-02       Impact factor: 1.056

2.  Structural Insights into TMB-1 and the Role of Residues 119 and 228 in Substrate and Inhibitor Binding.

Authors:  Susann Skagseth; Tony Christopeit; Sundus Akhter; Annette Bayer; Ørjan Samuelsen; Hanna-Kirsti S Leiros
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  Role of Residues W228 and Y233 in the Structure and Activity of Metallo-β-Lactamase GIM-1.

Authors:  Susann Skagseth; Trine Josefine Carlsen; Gro Elin Kjæreng Bjerga; James Spencer; Ørjan Samuelsen; Hanna-Kirsti S Leiros
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

4.  Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.

Authors:  Laura Martínez-García; José M González-Alba; Fernando Baquero; Rafael Cantón; Juan Carlos Galán
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867

Review 5.  The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.

Authors:  Dalal Hammoudi Halat; Carole Ayoub Moubareck
Journal:  Antibiotics (Basel)       Date:  2020-04-16

6.  OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs.

Authors:  Christopher Fröhlich; Vidar Sørum; Ane Molden Thomassen; Pål Jarle Johnsen; Hanna-Kirsti S Leiros; Ørjan Samuelsen
Journal:  mSphere       Date:  2019-03-27       Impact factor: 4.389

7.  Comparison of Verona Integron-Borne Metallo-β-Lactamase (VIM) Variants Reveals Differences in Stability and Inhibition Profiles.

Authors:  Anne Makena; Azer Ö Düzgün; Jürgen Brem; Michael A McDonough; Anna M Rydzik; Martine I Abboud; Ayşegül Saral; Ayşegül Ç Çiçek; Cemal Sandalli; Christopher J Schofield
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

8.  Comprehensive exploration of the translocation, stability and substrate recognition requirements in VIM-2 lactamase.

Authors:  John Z Chen; Douglas M Fowler; Nobuhiko Tokuriki
Journal:  Elife       Date:  2020-06-08       Impact factor: 8.140

9.  ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens In Vivo.

Authors:  Ørjan Samuelsen; Ove Alexander Høgmoen Åstrand; Christopher Fröhlich; Adam Heikal; Susann Skagseth; Trine Josefine Olsen Carlsen; Hanna-Kirsti S Leiros; Annette Bayer; Christian Schnaars; Geir Kildahl-Andersen; Silje Lauksund; Sarah Finke; Sandra Huber; Tor Gjøen; Adriana Magalhaes Santos Andresen; Ole Andreas Økstad; Pål Rongved
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.